Inhibition of α, βI, δ, η and ζ protein kinase C isoforms by xanthonolignoids

25Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The effect of the xanthonolignoids trans-(±)-kielcorin C, cis-(±)-kielcorin C, trans-(±)-kielcorin D, trans-(±)-isokielcorin D and trans-(±)-kielcorin E on isoforms α, βI, δ, η and ζ of protein kinase C (PKC) was studied using the yeast phenotypic assay. All the compounds tested revealed an effect compatible with PKC inhibition, similar to that exhibited by the well established PKC inhibitor chelerythrine, and with differences in their potency towards the distinct isoforms tested, being, in general, potent inhibitors of the atypical PKC isoform (PKC-ζ). PKC inhibition caused by these kielcorins was confirmed using an in vitro kinase assay. The present study constitutes the first attempt to unravel the molecular mechanism of kielcorins activity, and shows that xanthonolignoids are a promising group of compounds to investigate for isoform selective PKC inhibitors.

Cite

CITATION STYLE

APA

Saraiva, L., Fresco, P., Pinto, E., Sousa, E., Pinto, M., & Gonçalves, J. (2003). Inhibition of α, βI, δ, η and ζ protein kinase C isoforms by xanthonolignoids. Journal of Enzyme Inhibition and Medicinal Chemistry, 18(4), 357–370. https://doi.org/10.1080/147563601000118400

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free